OrthoXel's Vertex Hip Fracture Nail system obtains US clearance [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
The Vertex HFN is designed to address common challenges faced in hip fracture management such as instability and high cutout rates, which can impede patient recovery and mobility. OrthoXel's system aims to provide a stable and versatile solution for surgeons, enhancing the surgical procedure and potentially improving patient outcomes. The system features two proximal interdigitating screws for enhanced fixation and a radially fluted nail stem for rotational stability, particularly in critical regions of the femur. Furthermore, the Vertex HFN includes three proximal construct options, allowing for customisation based on intra-operative requirements. These options include two interdigitating lag screw configurations with different placements and a solid lag screw for a more traditional approach. OrthoXel said the intuitive design of the Vertex system allows it to be integrated seamlessly into existing surgical workflows. The implants and instruments come with radiographic g
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $480.00 to $500.00. They now have an "outperform" rating on the stock.MarketBeat
- Harding Loevner Global Equity Composite Q1 2024 Report [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Got $500? 3 Pharma Stocks to Buy and Hold Forever [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 5/31/24 - Form 4
- 5/31/24 - Form 144
- 5/30/24 - Form 4
- VRTX's page on the SEC website